 | Up a level |
Khan, Safi U; Yedlapati, Siva H; Lone, Ahmad N; Hao, Qiukui; Guyatt, Gordon; Delvaux, Nicolas; Bekkering, Geertruida E Trudy; Vandvik, Per Olav; Riaz, Irbaz Bin; Li, Sheyu; Aertgeerts, Bert; Rodondi, Nicolas (2022). PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis. BMJ, 377, e069116. BMJ Publishing Group 10.1136/bmj-2021-069116
